These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 37896988)
1. Next Generation Mucosal Vaccine Strategy for Respiratory Pathogens. Dotiwala F; Upadhyay AK Vaccines (Basel); 2023 Oct; 11(10):. PubMed ID: 37896988 [TBL] [Abstract][Full Text] [Related]
2. A novel simian adenovirus-vectored COVID-19 vaccine elicits effective mucosal and systemic immunity in mice by intranasal and intramuscular vaccination regimens. Zhang P; Luo S; Zou P; Deng Q; Wang C; Li J; Cai P; Zhang L; Li C; Li T Microbiol Spectr; 2023 Dec; 11(6):e0179423. PubMed ID: 37877750 [TBL] [Abstract][Full Text] [Related]
3. Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5. Diem G; Jäger M; Dichtl S; Bauer A; Lass-Flörl C; Reindl M; Wilflingseder D; Posch W Microbiol Spectr; 2023 Jun; 11(3):e0516322. PubMed ID: 37098903 [TBL] [Abstract][Full Text] [Related]
4. Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2. Afkhami S; D'Agostino MR; Zhang A; Stacey HD; Marzok A; Kang A; Singh R; Bavananthasivam J; Ye G; Luo X; Wang F; Ang JC; Zganiacz A; Sankar U; Kazhdan N; Koenig JFE; Phelps A; Gameiro SF; Tang S; Jordana M; Wan Y; Mossman KL; Jeyanathan M; Gillgrass A; Medina MFC; Smaill F; Lichty BD; Miller MS; Xing Z Cell; 2022 Mar; 185(5):896-915.e19. PubMed ID: 35180381 [TBL] [Abstract][Full Text] [Related]
5. An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection. van der Ley PA; Zariri A; van Riet E; Oosterhoff D; Kruiswijk CP Front Immunol; 2021; 12():781280. PubMed ID: 34987509 [TBL] [Abstract][Full Text] [Related]
8. Intranasal delivery of an adenovirus-vector vaccine co-expressing a modified spike protein and a genetic adjuvant confers lasting mucosal immunity against SARS-CoV-2. Jung HE; Ku KB; Kang BH; Park JH; Kim HC; Kim KD; Lee HK Antiviral Res; 2023 Aug; 216():105656. PubMed ID: 37327877 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of mucosal and systemic immune responses elicited by GPI-0100- adjuvanted influenza vaccine delivered by different immunization strategies. Liu H; Patil HP; de Vries-Idema J; Wilschut J; Huckriede A PLoS One; 2013; 8(7):e69649. PubMed ID: 23936066 [TBL] [Abstract][Full Text] [Related]
14. Simultaneous approach using systemic, mucosal and transcutaneous routes of immunization for development of protective HIV-1 vaccines. Belyakov IM; Ahlers JD Curr Med Chem; 2011; 18(26):3953-62. PubMed ID: 21824096 [TBL] [Abstract][Full Text] [Related]
15. Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection. Nagai M; Moriyama M; Ichinohe T mBio; 2021 Aug; 12(4):e0159821. PubMed ID: 34399617 [TBL] [Abstract][Full Text] [Related]
16. An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa. Vesin B; Lopez J; Noirat A; Authié P; Fert I; Le Chevalier F; Moncoq F; Nemirov K; Blanc C; Planchais C; Mouquet H; Guinet F; Hardy D; Vives FL; Gerke C; Anna F; Bourgine M; Majlessi L; Charneau P Mol Ther; 2022 Sep; 30(9):2984-2997. PubMed ID: 35484842 [TBL] [Abstract][Full Text] [Related]
17. [Immunity and antiviral vaccinations. Example: the respiratory mucosa]. Denis F; Hantz S; Alain S Antibiotiques (Paris); 2007 May; 9(2):130-138. PubMed ID: 32288532 [TBL] [Abstract][Full Text] [Related]
18. Mucosal Immune Response in Nasal-Associated Lymphoid Tissue upon Intranasal Administration by Adjuvants. Takaki H; Ichimiya S; Matsumoto M; Seya T J Innate Immun; 2018; 10(5-6):515-521. PubMed ID: 29860261 [TBL] [Abstract][Full Text] [Related]
19. PIKA provides an adjuvant effect to induce strong mucosal and systemic humoral immunity against SARS-CoV. Gai WW; Zhang Y; Zhou DH; Chen YQ; Yang JY; Yan HM Virol Sin; 2011 Apr; 26(2):81-94. PubMed ID: 21468931 [TBL] [Abstract][Full Text] [Related]
20. Mucosal Priming with a Recombinant Influenza A Virus-Vectored Vaccine Elicits T-Cell and Antibody Responses to HIV-1 in Mice. Wang J; Shu T; Deng W; Zheng Y; Liao M; Ye X; Han L; He P; Zheng X; Li T; Feng Y; Hu F; Li P; Sun C; Chen L; Li F; Feng L J Virol; 2021 May; 95(12):. PubMed ID: 33789991 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]